Status and phase
Conditions
Treatments
About
Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.
Full description
rhTPO
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
250 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
ZONGHONG SHAO, MD.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal